Jay R. Luly
2019
Compensation breakdown
| Non-Equity Incentive Plan | $337,326 |
|---|---|
| Option Awards | $3,027,598 |
| Salary | $641,825 |
| Stock Awards | $457,603 |
| Other | $19,151 |
| Total | $4,483,503 |
Luly received $3M in option awards, accounting for 68% of the total pay in 2019.
Luly also received $337.3K in non-equity incentive plan, $641.8K in salary, $457.6K in stock awards and $19.2K in other compensation.
Rankings
In 2019, Jay R. Luly's compensation ranked 2,566th out of 13,971 executives tracked by ExecPay. In other words, Luly earned more than 81.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,566 out of 13,971 | 82nd |
Division Manufacturing | 920 out of 5,701 | 84th |
Major group Chemicals And Allied Products | 301 out of 2,200 | 86th |
Industry group Drugs | 242 out of 1,886 | 87th |
Industry Pharmaceutical Preparations | 176 out of 1,398 | 87th |
Pay ratio
| Jay R. Luly's Pay | $4,483,503 |
|---|---|
| Median Employee's Pay | $260,099 |
| Pay Ratio | 17to 1 |
In 2019, the annual total compensation of Jay R. Luly was $4,483,503.
The annual total compensation of the median employee at Enanta Pharmaceuticals was $260,099.
The ratio of Jay R. Luly's pay to the pay of median employee was therefore 17 to one.
Luly's colleagues
We found four more compensation records of executives who worked with Jay R. Luly at Enanta Pharmaceuticals in 2019.
News
January 20, 2023
January 21, 2022
January 21, 2021
January 17, 2020
January 18, 2019